How a collaborative task force can assist in managing biotechnology products.

Area of Science:

• Pharmaceutical Science
• Health Policy
• Biotechnology

Background:

• The increasing prevalence of biotechnology-derived pharmaceuticals introduces complexities in healthcare management, including formulary decisions, usage protocols, and financial planning.
• Existing healthcare systems face challenges in adapting to the unique needs of biopharmaceuticals.

Purpose of the Study:

• To establish a collaborative forum for healthcare professionals and administrators to address challenges posed by biopharmaceuticals.
• To develop and implement a strategic framework for evaluating and forecasting the utilization of biopharmaceuticals.
• To enhance educational initiatives and database infrastructure for effective biopharmaceutical management and monitoring.

Main Methods:

• Formation of a Biotechnology Task Force by a DUE/QA pharmacy network and a hospital association.
• Development of information exchange forums for practitioners and administrators.
• Implementation of strategies for evaluating and predicting biopharmaceutical usage patterns.
• Creation of database technology for institutional usage monitoring.

Main Results:

• Successful education of healthcare professionals and administrators regarding the implications of biopharmaceuticals.
• Establishment of a defined process for the evaluation and management of biopharmaceuticals.
• Facilitation of information exchange and collaborative problem-solving.

Conclusions:

• The established process provides a valuable framework for the future evaluation of emerging biopharmaceuticals.
• Proactive collaboration and strategic planning are essential for integrating novel biotechnologies into healthcare.
• The task force model demonstrated effectiveness in addressing the complexities of biopharmaceutical adoption.